ISSN:

Journal Home

Blood Cancer Journal Q1 Unclaimed

Nature Publishing Group United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Blood Cancer Journal is a journal indexed in SJR in Hematology and Oncology with an H index of 76. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 3690 €. The scope of the journal is focused on hematologic malignancies, blood cancer, immunology. It has an SJR impact factor of 3,974 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,974.

Blood Cancer Journal focuses its scope in these topics and keywords: patients, monoclonal, cell, risk, nk, groups, introduction, myelofibrosis, increased, impacted, ...

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Hematology (Q1) Oncology (Q1)

Price

3690 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

3,974

SJR Impact factor

76

H Index

186

Total Docs (Last Year)

488

Total Docs (3 years)

5144

Total Refs

3636

Total Cites (3 years)

298

Citable Docs (3 years)

7.48

Cites/Doc (2 years)

27.66

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Journal of Hematology and Oncology Q1
Blood Q1
The Lancet Haematology Q1
Leukemia Q1
Blood advances Q1

Compare this journals